Skip to main content
. 2022 Apr 6;38(3):232–239. doi: 10.1089/jop.2021.0116

Table 2.

In Vitro Cellular Proliferation Study

Treatments 6 h 24 h 48 h 72 h
BSS 100 ± 4.06 100 ± 3.45 100 ± 3.14 100 ± 2.25
Reg P. –Ab 88.7 ± 4.32 65.7 ± 3.87 51.3 ± 3.65 30.1 ± 3.14
Reg_P +Ab 78.3 ± 4.98 58.3 ± 4.01 42.7 ± 3.49 21.3 ± 2.68
Dil_P –Ab 92.7 ± 5.32 82.7 ± 4.87 58.3 ± 2.87 50.1 ± 2.98
Dil_P +Ab 85.5 ± 3.24 75.6 ± 2.54 51.1 ± 4.21 45.7 ± 3.65

Reg P., regular proparacaine (0.5%); Dil. P, diluted proparacaine (0.05%); +Ab treated with antibiotics; −Ab not treated with antibiotics. At 6 h, viability was significantly affected, P < 0.01 (in Reg. P); and at 24, 48, and 72 h, the cellular viability was significantly affected, P < 0.001 (in Reg. P and Dil. P).